flurbiprofen has been researched along with Hyperemia in 4 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
Hyperemia: The presence of an increased amount of blood in a body part or an organ leading to congestion or engorgement of blood vessels. Hyperemia can be due to increase of blood flow into the area (active or arterial), or due to obstruction of outflow of blood from the area (passive or venous).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of a combined topical drug with flurbiprofen and cetylpyridinium chloride in patients with sore throat caused by upper respiratory tract infections." | 9.51 | [Results of a clinical study of the combination of flurbiprofen and cetylpyridinium chloride in patients with sore throat]. ( Galustyan, AN; Gonik, MI; Sedavnykh, IS, 2022) |
| "To evaluate the efficacy and safety of a combined topical drug with flurbiprofen and cetylpyridinium chloride compared with a monocomponent drug in patients with sore throat associated with manifestations of acute pharyngitis, tonsillitis or with exacerbation of chronic forms of pharyngitis or tonsillitis." | 9.51 | [Results of the clinical study of the combination of flurbiprofen and cetylpyridinium chloride in patients with sore throat]. ( Galustyan, AN; Poromov, AA; Sedavnykh, IS, 2022) |
| "To evaluate the efficacy and safety of a combined topical drug with flurbiprofen and cetylpyridinium chloride in patients with sore throat caused by upper respiratory tract infections." | 5.51 | [Results of a clinical study of the combination of flurbiprofen and cetylpyridinium chloride in patients with sore throat]. ( Galustyan, AN; Gonik, MI; Sedavnykh, IS, 2022) |
| "To evaluate the efficacy and safety of a combined topical drug with flurbiprofen and cetylpyridinium chloride compared with a monocomponent drug in patients with sore throat associated with manifestations of acute pharyngitis, tonsillitis or with exacerbation of chronic forms of pharyngitis or tonsillitis." | 5.51 | [Results of the clinical study of the combination of flurbiprofen and cetylpyridinium chloride in patients with sore throat]. ( Galustyan, AN; Poromov, AA; Sedavnykh, IS, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galustyan, AN | 4 |
| Sedavnykh, IS | 4 |
| Gonik, MI | 1 |
| Poromov, AA | 3 |
| Struck, HG | 1 |
| Giessler, S | 1 |
| Giessler, C | 1 |
| Hersh, PS | 1 |
| Rice, BA | 1 |
| Baer, JC | 1 |
| Wells, PA | 1 |
| Lynch, SE | 1 |
| McGuigan, LJ | 1 |
| Foster, CS | 1 |
2 trials available for flurbiprofen and Hyperemia
| Article | Year |
|---|---|
[Results of a clinical study of the combination of flurbiprofen and cetylpyridinium chloride in patients with sore throat].
Topics: Adult; Cetylpyridinium; Double-Blind Method; Flurbiprofen; Humans; Hyperemia; Pain; Pharyngitis; Pro | 2022 |
[Results of the clinical study of the combination of flurbiprofen and cetylpyridinium chloride in patients with sore throat].
Topics: Adult; Cetylpyridinium; Double-Blind Method; Flurbiprofen; Humans; Hyperemia; Pain; Pain Measurement | 2022 |
[Results of the clinical study of the combination of flurbiprofen and cetylpyridinium chloride in patients with sore throat].
Topics: Adult; Cetylpyridinium; Double-Blind Method; Flurbiprofen; Humans; Hyperemia; Pain; Pain Measurement | 2022 |
[Results of the clinical study of the combination of flurbiprofen and cetylpyridinium chloride in patients with sore throat].
Topics: Adult; Cetylpyridinium; Double-Blind Method; Flurbiprofen; Humans; Hyperemia; Pain; Pain Measurement | 2022 |
[Results of the clinical study of the combination of flurbiprofen and cetylpyridinium chloride in patients with sore throat].
Topics: Adult; Cetylpyridinium; Double-Blind Method; Flurbiprofen; Humans; Hyperemia; Pain; Pain Measurement | 2022 |
[Results of the clinical study of the combination of flurbiprofen and cetylpyridinium chloride in patients with sore throat].
Topics: Adult; Cetylpyridinium; Double-Blind Method; Flurbiprofen; Humans; Hyperemia; Pain; Pain Measurement | 2022 |
[Results of the clinical study of the combination of flurbiprofen and cetylpyridinium chloride in patients with sore throat].
Topics: Adult; Cetylpyridinium; Double-Blind Method; Flurbiprofen; Humans; Hyperemia; Pain; Pain Measurement | 2022 |
[Results of the clinical study of the combination of flurbiprofen and cetylpyridinium chloride in patients with sore throat].
Topics: Adult; Cetylpyridinium; Double-Blind Method; Flurbiprofen; Humans; Hyperemia; Pain; Pain Measurement | 2022 |
[Results of the clinical study of the combination of flurbiprofen and cetylpyridinium chloride in patients with sore throat].
Topics: Adult; Cetylpyridinium; Double-Blind Method; Flurbiprofen; Humans; Hyperemia; Pain; Pain Measurement | 2022 |
[Results of the clinical study of the combination of flurbiprofen and cetylpyridinium chloride in patients with sore throat].
Topics: Adult; Cetylpyridinium; Double-Blind Method; Flurbiprofen; Humans; Hyperemia; Pain; Pain Measurement | 2022 |
2 other studies available for flurbiprofen and Hyperemia
| Article | Year |
|---|---|
[Effect of non-steroidal anti-inflammatory drugs on inflammatory reaction. An animal experiment study].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Burns, Chemical; Conjunctiva; Cornea; Eye Burns; F | 1995 |
Topical nonsteroidal agents and corneal wound healing.
Topics: Administration, Topical; Analysis of Variance; Animals; Collagen; Cornea; Corneal Edema; Corneal Inj | 1990 |